Skip to main content
Epigral Limited logo

Epigral Limited — Investor Relations & Filings

Ticker · EPIGRAL ISIN · INE071N01016 LEI · 3358008YTT28JYLL4516 BSE.NS Manufacturing
Open in API
Filings indexed 551 across all filing types
Latest filing 2024-08-17 Regulatory Filings
Country IN India
Listing BSE.NS EPIGRAL

About Epigral Limited

https://epigral.com/

Epigral Limited, formerly Meghmani Finechem Limited, operates an integrated chemical complex specializing in chlor-alkali and derivative products. The company’s core portfolio includes caustic soda, chlorine, and hydrogen, which serve as building blocks for its value-added downstream products. Key offerings include chloromethanes, hydrogen peroxide, and CPVC resin. Epigral is the first domestic producer of Epichlorohydrin (ECH), utilizing a bio-based manufacturing process. Its products are essential inputs for various applications in pharmaceuticals, textiles, water treatment, and plastics. The company focuses on expanding its specialty chemical portfolio through backward and forward integration, utilizing advanced technology to optimize production efficiency and meet the requirements of diverse global markets.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings Classification · 95% confidence The document is a detailed notice of a Postal Ballot issued by Epigral Limited, addressed to stock exchanges and shareholders. It references compliance with SEBI Listing Regulations, Companies Act provisions, and MCA circulars. The notice seeks shareholder approval for a special resolution related to fund raising by issuance of equity shares and/or equity-linked securities up to 500 Crores. It includes procedural details about e-voting, the appointment of a scrutinizer, and timelines for voting and result declaration. The document is not a report itself but a formal announcement and solicitation of shareholder votes on a specific corporate action. It does not contain financial statements or management discussion but is a regulatory disclosure under SEBI regulations about a shareholder vote via postal ballot. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it pertains to the process and notice for shareholder voting. However, since this document is the notice for the postal ballot and not the actual voting results, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the voting process rather than the voting results or a report. The document length and content confirm it is not a brief announcement but a full notice, yet it is not a report or results declaration. Hence, Regulatory Filings (RNS) is the most appropriate classification.
2024-08-17 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a board meeting held on August 14, 2024. It details the board's approval to raise funds through issuance of securities up to Rs. 500 Crores, the constitution of a committee for the fund raising, and the issuance of a notice for a shareholders meeting to approve the fund raising. The document references SEBI regulations related to capital raising and disclosures. It does not contain financial statements or detailed financial analysis but is an announcement of corporate actions related to capital raising. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 6639 characters, which is sufficient for a detailed announcement but not a full financial report. Hence, the classification is CAP with high confidence.
2024-08-14 English
Outcome of Board Meeting
Capital/Financing Update Classification · 100% confidence The document is a formal letter addressed to stock exchanges reporting the outcome of a Board Meeting held on August 14, 2024. The key content is about the Board approving a proposal to raise funds through issuance of securities up to Rs. 500 Crores, including details about the type of securities, issuance method, and regulatory compliance under SEBI regulations. It also mentions the constitution of a committee and the issuance of a notice to shareholders for approval. The document is an announcement of a corporate action related to capital raising and financing activities. It does not contain financial statements or detailed financial performance data, nor is it a transcript, report, or voting result. The document fits the category of Capital/Financing Update (CAP) as it provides an update on the company's fundraising plans and related board decisions.
2024-08-14 English
Board Meeting — EPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2024 to consider Fund raising.
Regulatory Filings
2024-08-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the company's participation in an investor conference (Emkay Confluence 2024) scheduled for August 12, 2024. It is an intimation under SEBI regulations about an event, not a financial report, audit, or detailed presentation. The document length is only 1536 characters, indicating it is a brief announcement rather than a full report. There is no financial data, no voting results, no management changes, no legal proceedings, or other detailed content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the schedule of meetings with institutional investors through a Non-Deal Roadshow. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document mentions that the latest Earnings Presentation and Corporate Presentation are already available on the company's website, but this document itself is only an announcement of the schedule of investor meetings. It does not contain any financial data, earnings results, or detailed presentations. The document length is short (2048 characters), and it serves as an informational notice rather than a report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-07-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.